The injectable drug delivery market in India is witnessing rapid growth, driven by rising demand for chronic disease treatments, oncology care, and critical care solutions. However, significant challenges persist, including the high cost of medications, limited access in underserved regions, and the stringent requirements for product safety and sterility. For patients and healthcare providers alike, the complexities of drug administration and the absence of advanced formulations further complicate treatment. Positioned as one of the leaders in this sector, Jodas Expoim addresses these hurdles by offering affordable, high-quality generic injectables, broadening accessibility, and ensuring rigorous safety standards at its cutting-edge facilities.

Pioneering Accessible Healthcare Solutions
Established in 2007, Jodas Expoim is a research-driven pharmaceutical company dedicated to providing innovative and affordable healthcare solutions. Operating in over 50 countries, the company has quickly established itself as a prominent player in the injectable drug delivery market, excelling in key therapeutic areas such as oncology, anti-infectives, contrast media, and critical care. Jodas Expoim’s portfolio includes a diverse range of injectables, from cephalosporins and lyophilized powders to novel drug delivery systems designed to enhance product stability and extend shelf life.

The company further strengthens its focus on oncology, contrast media, and critical care injectables by consistently addressing patient needs through innovative formulations. Jodas Expoim’s commitment to cost-effectiveness and patient safety ensures its solutions cater to both urban and rural markets. The introduction of user-friendly injectors and advanced delivery systems such as prefilled syringes and lyophilized powders simplifies drug storage and administration, making these products a preferred choice for healthcare providers worldwide.

“

With EU-GMP certified facilities JODAS Expoim Pvt. upholds rigorous standards through testing & ensuring superior quality

---

Delivering Quality and Innovation on a Global Scale
At the heart of Jodas Expoim's operations lies an unwavering commitment to quality, safety, and accessibility. This dedication is exemplified by the company’s certifications from nine global regulatory bodies, including the EU, Russia, PIC/s, UAE, and SFDA. With EU-GMP-certified manufacturing facilities, Jodas Expoim ensures unparalleled sterility and precision in its production processes. A focus on extended product shelf life, efficient inventory management, and broad distribution networks allows Jodas Expoim to reach underserved areas, ensuring that its injectables are accessible to a wider patient base.

In collaboration with healthcare providers, Jodas Expoim has launched several outreach programs aimed at enhancing medical access in underserved regions of India. By partnering with local governments and NGOs, the company has created a significant impact on healthcare availability in remote areas, addressing a crucial gap in the system.

In addition to its high-quality products, Jodas Expoim prioritizes patient outcomes through comprehensive post-delivery support, helping to monitor treatment compliance and effectiveness. Supported by over 900 employees and an indirect workforce of 1,500, Jodas Expoim rigorously adheres to stringent testing protocols, ensuring each product meets the highest standards of excellence. The company's robust R&D capabilities also enable it to remain at the forefront of pharmaceutical innovation, continuously enhancing its offerings to meet evolving market demands.

Driving Future Growth and Innovation
Jodas Expoim is poised to expand its product portfolio with cutting-edge innovations such as oligonucleotides and biosimilars. These new products will offer more personalized treatment options, reinforcing the company’s position as a leader in the injectable drug delivery market.

Moreover, the company is exploring environmentally sustainable production processes, aiming to minimize its carbon footprint while enhancing production efficiency. With highly automated workflows and the seamless integration of advanced technologies, Jodas optimizes efficiency, reduces human intervention, and streamlines processes, ensuring consistently superior outcomes across all aspects of healthcare.

Committed to delivering high-quality, safe, and affordable healthcare solutions, Jodas Expoim is well-positioned to drive the next wave of pharmaceutical advancements, transforming healthcare on a global scale.